[Study of blood copper as an early screening test in aggravated dysplasia and cancer of the cervix uteri]. / Etude de la cuprémie comme test de dépistage précoce dans les dysplasies aggravées et dans le cancer du col utérin.

PIP: Blood copper levels were studied in 100 patients with suspicious lesions of the uterine cervix of which 31 were simple dysplasia, 48 were aggravated dysplasia, and 21 were cervical cancer. While normal blood copper levels do not exclude the possibility of malignancy, levels greater than 130 mcg per 100 ml call for close supervision of an aggravated dysplasia. Levels greater than 199 mcg per 100 ml should arouse suspicion of incipient carcinoma (microcarcinoma or invasive carcinoma).^ieng